Eyal Gottlieb

机构：The University of Texas MD Anderson Cancer Center, Technion – Israel Institute of Technology, Rappaport Family Institute for Research in the Medical Sciences, Louisiana State University Health Sciences Center Shreveport · ORCID：0000-0002-9770-0956

发表论文 317 篇 · 总被引 45887 次 · h-index 77

代表论文

• Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD (2024 · Cell Metabolism · 被引 74)
• Programming a Ferroptosis‐to‐Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy (2024 · Advanced Science · 被引 48)
• Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells (2023 · Nature Metabolism · 被引 40)
• Genetically engineering glycolysis in T cells increases their antitumor function (2024 · Journal for ImmunoTherapy of Cancer · 被引 27)
• Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis (2024 · Nature Metabolism · 被引 26)
• Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort (2024 · Nature Communications · 被引 24)